BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 1589566)

  • 21. Retrograde effects of triazolam and zolpidem on sleep-dependent motor learning in humans.
    Morgan PT; Kehne JH; Sprenger KJ; Malison RT
    J Sleep Res; 2010 Mar; 19(1 Pt 2):157-64. PubMed ID: 19682231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversal of triazolam- and zolpidem-induced memory impairment by flumazenil.
    Wesensten NJ; Balkin TJ; Davis HQ; Belenky GL
    Psychopharmacology (Berl); 1995 Sep; 121(2):242-9. PubMed ID: 8545530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects.
    Feige B; Voderholzer U; Riemann D; Hohagen F; Berger M
    Clin Neurophysiol; 1999 Nov; 110(11):1965-74. PubMed ID: 10576495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
    Mintzer MZ; Frey JM; Griffiths RR
    Behav Pharmacol; 1998 Nov; 9(7):545-59. PubMed ID: 9862080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of zolpidem on sleep architecture, night time ventilation, daytime vigilance and performance in heavy snorers.
    Quera-Salva MA; McCann C; Boudet J; Frisk M; Borderies P; Meyer P
    Br J Clin Pharmacol; 1994 Jun; 37(6):539-43. PubMed ID: 7917771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Daytime wakefulness following a bedtime oral dose of zolpidem 20 mg, flunitrazepam 2 mg and placebo.
    Bensimon G; Foret J; Warot D; Lacomblez L; Thiercelin JF; Simon P
    Br J Clin Pharmacol; 1990 Sep; 30(3):463-9. PubMed ID: 2223425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
    Rush CR; Baker RW; Rowlett JK
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose response effects of zolpidem in normal geriatric subjects.
    Scharf MB; Mayleben DW; Kaffeman M; Krall R; Ochs R
    J Clin Psychiatry; 1991 Feb; 52(2):77-83. PubMed ID: 1993640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of zolpidem and triazolam on sleep and respiration in mild to moderate chronic obstructive pulmonary disease.
    Steens RD; Pouliot Z; Millar TW; Kryger MH; George CF
    Sleep; 1993 Jun; 16(4):318-26. PubMed ID: 8341892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
    Rowlett JK; Woolverton WL
    J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M; Attali P; Coquelin JP
    Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Administration of triazolam prior to recovery sleep: effects on sleep architecture, subsequent alertness and performance.
    Balkin TJ; O'Donnell VM; Kamimori GH; Redmond DP; Belenky G
    Psychopharmacology (Berl); 1989; 99(4):526-31. PubMed ID: 2594919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
    Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI
    J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of zolpidem, triazolam, and placebo as hypnotic drugs the night before surgery.
    Morgan PJ; Chapados R; Chung FF; Gauthier M; Knox JW; Le Lorier J
    J Clin Anesth; 1997 Mar; 9(2):97-102. PubMed ID: 9075032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers.
    Fairweather DB; Kerr JS; Hindmarch I
    Eur J Clin Pharmacol; 1992; 43(6):597-601. PubMed ID: 1493840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal by caffeine of triazolam-induced impairment of waking function.
    Roehrs T; Zwyghuizen-Doorenbos A; Smith D; Zorick F; Roth T
    Psychopharmacol Ser; 1988; 6():194-202. PubMed ID: 3217412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep-related vagotonic effect of zolpidem in rats.
    Chen HY; Kuo TB; Shaw FZ; Lai CJ; Yang CC
    Psychopharmacology (Berl); 2005 Sep; 181(2):270-9. PubMed ID: 15778879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of zolpidem on daytime alertness, psychomotor and physical performance.
    Ito SU; Kanbayashi T; Takemura T; Kondo H; Inomata S; Szilagyi G; Shimizu T; Nishino S
    Neurosci Res; 2007 Nov; 59(3):309-13. PubMed ID: 17825448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of daytime administration of zolpidem and triazolam on performance.
    Wesensten NJ; Balkin TJ; Belenky GL
    Aviat Space Environ Med; 1996 Feb; 67(2):115-20. PubMed ID: 8834935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects in humans after repeated administrations of zolpidem and triazolam.
    Stoops WW; Rush CR
    Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.